Blog
RSS FeedPosted by Michael Wonder on 03 Oct 2016
NICE says no to daclizumab (Zinbryta)
3 October 2016 - The MS Trust is disappointed that NICE does not intend to recommend that daclizumab (Zinbryta) be made ...
Posted by Michael Wonder on 03 Oct 2016
NHS watchdog ready to impose hefty fees for approving drugs
1 October 2016 - NICE’s cost hike could deter start-ups and delay lifesaving treatments. ...
Posted by Michael Wonder on 29 Sep 2016
More on NICE recommendation of Imlygic
28 September 2016 - More on NICE's guidance on the use of talimogene laherparepvec for unresectable metastatic melanoma. ...
Posted by Michael Wonder on 29 Sep 2016
NICE rejects LIlly's Portrazza
28 September 2016 - NICE is not in favour of the use of Portrazza on the NHS. ...
Posted by Michael Wonder on 28 Sep 2016
NICE recommends the reimbursement of Imlygic
28 September 2016 - NICE has recommended the relimbursement of Amgen's new cellular therapy for patients with malignant melanoma. ...
Posted by Michael Wonder on 28 Sep 2016
Patients with BRVO, a sight threatening eye condition, now have first-line access to EYLEA (aflibercept solution for injection) on the NHS
28 September 2016 - Bayer is pleased to announce that NICE has made the final recommendation for aflibercept for the treatment ...
Posted by Michael Wonder on 27 Sep 2016
NICE sets out proposed technology assessment fees
18 September 2016 - NICE in the UK has been exploring the idea of charging the pharmaceutical industry for technology ...
Posted by Michael Wonder on 23 Sep 2016
NICE says yes to another hepatitis C drug
23 September 2016 - A new drug which effectively treats more genotypes of hepatitis C has been recommended for use in ...
Posted by Michael Wonder on 23 Sep 2016
UK audit shows infliximab biosimilars are safe, effective, and cheap
22 September 2016 - Infliximab “biosimilars”—biological therapies engineered to work in the same way as the monoclonal antibody drug infliximab (Remicade)—are ...
Posted by Michael Wonder on 22 Sep 2016
43p drug that prevents spread of breast cancer denied to thousands
22 September 2016 - Thousands of women in the UK with breast cancer are being denied a 43p-a-day medicine ...
Posted by Michael Wonder on 22 Sep 2016
NICE to recommend new drug to treat rare inherited bone disorder in children
22 September 2016 - NICE recommends ‘lifeline’ drug for babies and young children, in draft guidance. ...
Posted by Michael Wonder on 19 Sep 2016
NICE says no to expanding scope of Roche’s IPF drug
19 September 2016 - Patients in England and Wales with the lung scarring disease idiopathic pulmonary fibrosis will have to wait ...
Posted by Michael Wonder on 15 Sep 2016
NICE published draft guidance on new use for Gazyva
15 September 2016 - The Department of Health has asked the NICE to produce guidance on using obinutuzumab in combination with ...
Posted by Michael Wonder on 09 Sep 2016
More options to be made available to treat hepatitis C
9 September 2016 - Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS. ...
Posted by Michael Wonder on 08 Sep 2016
Coil is more effective than pill as emergency contraception, says NICE
8 September 2016 - NICE is calling for women to be told that the coil is more effective than the ‘morning ...